Evidence map›Paper›PMID 23304067›Full record

ArticleMolecular vision2012

Two novel disease-causing mutations in the CLRN1 gene in patients with Usher syndrome type 3.

Gema García-García, María J Aparisi, Regina Rodrigo, María D Sequedo, Carmen Espinós, Jordi Rosell, José L Olea, M Paz Mendívil, María A Ramos-Arroyo, Carmen Ayuso and 3 more

Open access · greenAbstract read
In one paragraph

Article in Molecular vision, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.7field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Strategies for genetic study of hearing loss in the Brazilian northeastern region.International journal of molecular epidemiology and genetics · 2014
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 1 institution in 1 country.

Gema García-GarcíaGrupo de Investigación en Enfermedades Neurosensoriales, Instituto de Investigación Sanitaria IIS - La Fe, Valencia, Spain.
María J Aparisi
Regina Rodrigo
María D Sequedo
Carmen Espinós
Jordi Rosell
José L Olea
M Paz Mendívil
María A Ramos-Arroyo
Carmen Ayuso
Teresa Jaijo
Elena Aller
José M Millán
Instituto de Investigación Sanitaria La Fe · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo identify the genetic defect in Spanish families with Usher syndrome (USH) and probable involvement of the CLRN1 gene.

methodsDNA samples of the affected members of our cohort of USH families were tested using an USH genotyping array, and/or genotyped with polymorphic markers specific for the USH3A locus. Based on these previous analyses and clinical findings, CLRN1 was directly sequenced in 17 patients susceptible to carrying mutations in this gene.

resultsMicroarray analysis revealed the previously reported mutation p.Y63X in two unrelated patients, one of them homozygous for the mutation. After CLRN1 sequencing, we found two novel mutations, p.R207X and p.I168N. Both novel mutations segregated with the phenotype.

conclusionsTo date, 18 mutations in CLRN1 have been reported. In this work, we report two novel mutations and a third one previously identified in the Spanish USH sample. The prevalence of CLRN1 among our patients with USH is low.

Indexed as

MutationWhite PeopleAdultBase SequenceExonsFemaleGenetic LociGenotypeGenotyping TechniquesHumansMaleMembrane ProteinsMiddle AgedMolecular Sequence DataOligonucleotide Array Sequence AnalysisPedigreeCLRN1 protein, humanMembrane Proteins

Identifiers

PMID23304067
PMCPMC3538041
OpenAlexW2132489734

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.